Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
3(15%)
Results Posted
13%(1 trials)

Phase Distribution

Ph phase_2
4
20%
Ph phase_4
2
10%
Ph not_applicable
12
60%

Phase Distribution

0

Early Stage

4

Mid Stage

2

Late Stage

Phase Distribution18 total trials
Phase 2Efficacy & side effects
4(22.2%)
Phase 4Post-market surveillance
2(11.1%)
N/ANon-phased studies
12(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

20

all time

Status Distribution
Active(6)
Completed(8)
Other(6)

Detailed Status

Completed8
unknown6
Not yet recruiting3
Recruiting2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
20
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 24 (22.2%)
Phase 42 (11.1%)
N/A12 (66.7%)

Trials by Status

recruiting210%
unknown630%
not_yet_recruiting315%
active_not_recruiting15%
completed840%

Recent Activity

Clinical Trials (20)

Showing 20 of 20 trials
NCT06589700Not Applicable

B2AD-Risk AFDAS Evolution of Burden of AF

Recruiting
NCT07405359Not Applicable

PVI Alone Versus PVI Plus PWI and SVCI With PFA

Not Yet Recruiting
NCT06096246Not Applicable

Investigation of Cardioversion Versus Therapeutic Ablation for Persistent AF (ORBICA-AF)

Recruiting
NCT03907982Not Applicable

Investigation of Therapeutic Ablation Versus Cardioversion for AF

Completed
NCT03305250Not Applicable

Arrhythmia Burden, Risk of Sudden Cardiac Death and Stroke in Patients With Fabry Disease

Active Not Recruiting
NCT03974412Not Applicable

Syncope Trial to Understand Tilt Testing Early or Recorders Study

Completed
NCT06269692Not Applicable

MAgnetic Resonance Imaging-guided implanTation of Cardioverter DEFibrillators

Not Yet Recruiting
NCT05717504Not Applicable

Sweet spoT for cArdiac Rhythm monitorinG After sTrokE

Unknown
NCT05974306Not Applicable

Evaluation of a Proactive Clinical Management and Early Diagnosis of Arrhythmias in Patients With Heart Failure and Non Severely Reduced Left Ventricular Function Through a Telemonitoring System

Not Yet Recruiting
NCT01170559Not Applicable

Use of Loop Recorders for Diagnosis of Palpitations in A&E

Completed
NCT04627987

Mechanisms of Excess Risk in Aortic Stenosis

Unknown
NCT04055285Not Applicable

Effect of Renal Denervation on Atrial Fibrillation

Unknown
NCT01423994Phase 4

Syncope: Pacing or Recording in the Later Years

Completed
NCT02528604Phase 4

Electrical Cardioversion, Ablation or Pace and Ablate for Persistent Atrial Fibrillation

Completed
NCT03124576

Reappraisal of Atrial Fibrillation: RACE-V - Work Package 5

Unknown
NCT02617069Phase 2

Botulinum Toxin Injection Into Epicardial Fat Pads to Prevent Atrial Fibrillation in Patients Undergoing Cardiac Surgery

Unknown
NCT02984371Phase 2

Epicardial Fat Pads Ablation During Coronary Surgery

Unknown
NCT02041832Not Applicable

Detection of Subclinical Atrial Fibrillation in High Risk Patients Using Implantable Loop Recorder

Completed
NCT01842529Phase 2

Botulinum Toxin Injection in Epicardial Fat Pads To Treat Atrial Fibrillation After Cardiac Surgery

Completed
NCT01794416Phase 2

Thoracoscopic Versus Endocardial Ablation in Patient With Paroxysmal AF After Failed Initial Endocardial Ablation

Completed

All 20 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
20